PIII
Income statement / Annual
Last year (2025), P3 Health Partners Inc's total revenue was $1.46 B,
a decrease of 2.76% from the previous year.
In 2025, P3 Health Partners Inc's net income was -$147.95 M.
See P3 Health Partners Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.46 B |
$1.50 B |
$1.27 B |
$1.05 B |
$637.36 M |
$491.06 M |
$145.48 M |
$87.70 M |
| Cost of Revenue |
$1.60 B
|
$0.00
|
$0.00
|
$0.00
|
$668.07 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$144.32 M
|
$1.50 B
|
$1.27 B
|
$1.05 B
|
-$30.70 M
|
$491.06 M
|
$145.48 M
|
$87.70 M
|
| Gross Profit Ratio |
-0.1
|
1
|
1
|
1
|
-0.05
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$106.31 M
|
$112.60 M
|
$122.36 M
|
$157.28 M
|
$117.23 M
|
$53.39 M
|
$36.42 M
|
$28.54 M
|
| Selling & Marketing Expenses |
$918.00 K
|
$1.33 M
|
$3.23 M
|
$5.10 M
|
$2.18 M
|
$1.50 M
|
$801.69 K
|
$1.87 M
|
| Selling, General & Administrative Expenses |
$107.23 M
|
$113.93 M
|
$125.60 M
|
$162.38 M
|
$157.24 M
|
$54.89 M
|
$37.23 M
|
$30.41 M
|
| Other Expenses |
$18.75 M
|
$1.71 B
|
$1.31 B
|
$2.45 B
|
$46.56 M
|
$464.76 M
|
$147.79 M
|
-$103.73 K
|
| Operating Expenses |
$125.98 M
|
$1.82 B
|
$1.43 B
|
$2.61 B
|
$157.24 M
|
$519.65 M
|
$185.02 M
|
$137.41 M
|
| Cost And Expenses |
$1.73 B
|
$1.82 B
|
$1.43 B
|
$2.61 B
|
$825.31 M
|
$519.65 M
|
$185.02 M
|
$137.41 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$44.24 K
|
| Interest Expense |
$55.03 M
|
$22.17 M
|
$15.99 M
|
$11.40 M
|
$10.68 M
|
$2.53 M
|
$2.53 M
|
$0.00
|
| Depreciation & Amortization |
$84.16 M
|
$86.06 M
|
$86.68 M
|
$87.29 M
|
$8.72 M
|
$795.17 K
|
$399.18 K
|
$342.20 K
|
| EBITDA |
-$186.14 M |
-$197.76 M |
-$81.07 M |
-$1.46 B |
-$184.61 M |
-$28.08 M |
-$39.04 M |
-$49.37 M |
| EBITDA Ratio |
-0.13
|
-0.13
|
-0.06
|
-1.39
|
-0.29
|
-0.06
|
-0.27
|
-0.56
|
| Operating Income Ratio |
-0.19
|
-0.21
|
-0.13
|
-1.49
|
-0.29
|
-0.06
|
-0.27
|
-0.57
|
| Total Other Income/Expenses Net |
-$50.76 M
|
$6.61 M
|
-$15.80 M
|
$1.22 M
|
-$16.39 M
|
-$2.82 M
|
-$2.44 M
|
-$59.50 K
|
| Income Before Tax |
-$321.06 M
|
-$305.99 M
|
-$183.73 M
|
-$1.56 B
|
-$204.34 M
|
-$31.41 M
|
-$41.97 M
|
-$49.77 M
|
| Income Before Tax Ratio |
-0.22
|
-0.2
|
-0.15
|
-1.49
|
-0.32
|
-0.06
|
-0.29
|
-0.57
|
| Income Tax Expense |
$2.03 M
|
$4.39 M
|
$2.70 M
|
$1.86 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$147.95 M
|
-$135.85 M
|
-$57.77 M
|
-$270.13 M
|
-$156.48 M
|
-$31.41 M
|
-$41.97 M
|
-$43.80 M
|
| Net Income Ratio |
-0.1
|
-0.09
|
-0.05
|
-0.26
|
-0.25
|
-0.06
|
-0.29
|
-0.5
|
| EPS |
-45.26 |
-46.79 |
-30.44 |
-324.84 |
-188.17 |
-39.73 |
-44.1 |
-92.04 |
| EPS Diluted |
-45.26 |
-54.06 |
-30.44 |
-324.84 |
-188.17 |
-39.73 |
-44.1 |
-92.04 |
| Weighted Average Shares Out |
$3.27 M
|
$2.90 M
|
$1.90 M
|
$831.58 K
|
$831.58 K
|
$790.63 K
|
$475.88 K
|
$475.88 K
|
| Weighted Average Shares Out Diluted |
$3.27 M
|
$2.94 M
|
$1.90 M
|
$831.58 K
|
$831.58 K
|
$790.63 K
|
$475.88 K
|
$475.88 K
|
| Link |
|
|
|
|
|
|
|
|
